Search
Results for “insulin pump”
Drug facts and side effects, recalls, research, clinical trials and medical reference, from the FDA, the National Library of Medicine and this site.
Research
5,952 articles in PubMed, most relevant first
Insulin Pump Therapy (opens in a new tab)
Nimri R, Nir J, Phillip M
When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM) 2009 (opens in a new tab)
Lassmann-Vague V, Clavel S, Guerci B, et al.
Diabetes and Technology (opens in a new tab)
Simmons K, Riddley S
Insulin Pump Therapy Efficacy and Key Factors Influencing Adherence in Pediatric Population-A Narrative Review (opens in a new tab)
Trandafir LM, Moisa SM, Vlaiculescu MV, et al.
Associations between insulin pump self-management and HbA1c in type 1 diabetes (opens in a new tab)
Rytter K, Madsen KP, Andersen HU, et al.
Mechanisms and consequences of Na+,K+-pump regulation by insulin and leptin (opens in a new tab)
Sweeney G, Klip A
Clinical trials
1,080 studies on ClinicalTrials.gov
A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump (opens in a new tab)
Eli Lilly and Company
Medtronic Treat to Range (TTR) Closed-Loop Control (opens in a new tab)
Stanford University
System Accuracy Evaluation of 6 CE-marked Blood Glucose Monitoring System Following ISO 15197:2013 (opens in a new tab)
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
Accelerating Post-exercise Muscle Glycogen Resynthesis in Humans: Impact of Combined Nutrient Intake and Intermittent Pneumatic Compression or Heat Therapy (opens in a new tab)
PepsiCo Global R&D
Glycemic Control and Quality of Life With i- Port Advance in Pediatric T1DM (opens in a new tab)
Assaf-Harofeh Medical Center
Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients (opens in a new tab)
University of Texas Southwestern Medical Center
Recalls
14 FDA recalls in the last 3 years, newest first
-
Aug. 26, 2026
Device recall, ongoing
Minimed (3 items)
Medtronic Minimed
Why: Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
July 15, 2026
Device recall, ongoing
Minimed
Medtronic Minimed
Why: A software anomaly can occur when the pump is paired with the Instinct sensor. Under certain circumstances, the pump unexpectedly stops delivering insulin and displays two error messages back-to-back: Pump Error 53...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
May 6, 2026
Device recall, ongoing
Ilet Bionic Pancreas
Beta Bionics, sold nationwide
Why: insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
April 8, 2026
Device recall, ongoing
Minimed and Paradigm Real-Time Insulin Pump and 3 more (14 items)
Medtronic Minimed, sold nationwide
Why: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the...
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab) -
Feb. 11, 2026
Device recall, ongoing
Minimed
Medtronic Minimed
Why: A software timing and processor communication issue in MiniMed" 780G software version 6.60 may trigger Pump Error 43 and/or Pump Error 41, resulting in suspension of insulin delivery.
Class II: could cause temporary or reversible harm
The FDA record, with lot numbers (opens in a new tab)
9 more in the FDA's records. The FDA recall list (opens in a new tab)
Medical reference
StatPearls, for clinicians
Human Insulin (opens in a new tab)
Insulin Lispro (opens in a new tab)
Aspart Insulin (opens in a new tab)
Biochemistry, C Peptide (opens in a new tab)
See all 77 StatPearls chapters (opens in a new tab)
MedlinePlus, for patients
Diabetes Medicines (opens in a new tab)
What is diabetes? Diabetes is a disease in which your blood glucose, or blood sugar, levels are too high. Glucose comes from the foods you eat. The cells of your body need glucose for energy. A hormone called insulin...
Diabetes Type 1 (opens in a new tab)
What is type 1 diabetes? Diabetes means your blood glucose, also called blood sugar, is too high. With type 1 diabetes, your body makes little or no insulin. Insulin is a hormone from your pancreas that helps glucose...
Diabetes (opens in a new tab)
What is diabetes? Diabetes, also known as diabetes mellitus, is a disease in which your blood glucose, or blood sugar, levels are too high. Glucose is your body's main source of energy. Your body can make glucose, but it...
Research, trials and reference come from the National Library of Medicine (PubMed, ClinicalTrials.gov, StatPearls on the NCBI Bookshelf, MedlinePlus); drug facts, side-effect reports and recalls from the FDA. For reference, not medical advice.